Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

Accolade Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,436	17,254	18,107	24,264	22,103	18,187
Market Cap Growth	37.00%	-4.71%	-25.37%	9.78%	21.53%	-
Enterprise Value	15,795	17,625	17,747	24,232	21,769	17,754
Last Close Price	79.81	90.57	94.78	126.81	115.35	94.83
PE Ratio	39.91	44.42	59.57	104.27	129.00	188.35
Forward PE	31.23	29.85	46.16	81.03	105.28	140.78
PS Ratio	10.60	12.24	19.04	41.87	51.04	66.61
PB Ratio	5.79	6.55	7.69	12.64	12.70	11.75
P/TBV Ratio	7.35	8.30	9.93	14.01	14.16	12.74
P/FCF Ratio	141.01	944.35	-	-	-	3933.10
P/OCF Ratio	41.80	49.62	85.16	97.01	100.79	147.44
PEG Ratio	-	1.31	1.31	-	-	-
EV/Sales Ratio	10.84	12.50	18.66	41.82	50.27	65.02
EV/EBITDA Ratio	27.55	31.16	46.64	89.28	115.75	143.49
EV/EBIT Ratio	37.03	40.29	57.59	104.62	137.88	182.91
EV/FCF Ratio	144.30	964.66	-	-	-	3839.48
Debt / Equity Ratio	0.24	0.23	0.18	0.09	0.09	-
Debt / EBITDA Ratio	1.11	1.07	1.09	0.59	0.82	-
Debt / FCF Ratio	5.82	33.33	-	-	-	-
Asset Turnover	0.44	0.43	0.36	0.27	0.24	0.24
Inventory Turnover	2.07	2.11	1.77	1.31	1.18	0.73
Quick Ratio	3.21	2.86	2.05	6.39	7.37	13.83
Current Ratio	4.48	3.95	2.71	7.19	8.02	14.87
Return on Equity (ROE)	14.83%	15.51%	13.38%	12.42%	10.21%	8.76%
Return on Assets (ROA)	8.11%	8.34%	7.26%	6.75%	5.35%	5.22%
Return on Capital (ROIC)	8.87%	9.09%	7.93%	7.28%	5.73%	5.53%
Return on Capital Employed (ROCE)	13.10%	13.70%	11.50%	11.00%	8.30%	6.20%
Earnings Yield	2.45%	2.25%	1.68%	0.96%	0.78%	0.53%
FCF Yield	0.71%	0.11%	-0.87%	-0.09%	-0.42%	0.03%
Dividend Yield	0.34%	-	0.29%	0.22%	0.18%	0.16%
Payout Ratio	19.08%	18.17%	20.19%	19.10%	17.81%	-
Buyback Yield / Dilution	0.47%	0.27%	-0.25%	-0.17%	-17.57%	-13.96%
Total Shareholder Return	0.82%	0.27%	0.04%	0.06%	-17.39%	-13.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.